Abstract
There is accumulating evidence that chronic electroconvulsive shock (ECS) can increase the functional output of central dopaminergic systems. The present experiments investigated the effects of acute and chronic ECS on interstitial concentrations of dopamine (DA) in the nucleus accumbens (NAC) using in vivo microdialysis in awake freely moving rats. ECS (150 V, 0.75 s) increased interstitial concentrations of DA, DOPAC and HVA to approximately 130% of baseline values. The magnitude of the ECS-induced increase in DA was not affected by chronic ECS. In contrast, the response of the DA metabolites was attenuated in the chronic ECS group. Chronic ECS did not influence apomorphine (25 µg/kg, SC)-induced decreases in extracellular concentrations of DA or its metabolites in the NAC, thus providing no support for the hypothesis that chronic ECS produces subsensitivity of DA autoreceptors.d-Amphetamine (1.5 mg/kg SC)-induced increases in extracellular DA were significantly prolonged in the NAC of the chronic ECS group. In accordance with previous reports, the locomotor stimulant effects ofd-amphetamine were also enhanced in the chronic ECS group. These data provide further evidence that chronic ECS can increase certain behavioral and neurochemical indices of meso-accumbens DA function.
Similar content being viewed by others
Abbreviations
- DA:
-
dopamine
- NAC:
-
nucleus accumbens
- DOPAC:
-
3,4-dihydroxyphenylacetic acid
- HVA:
-
homovanillic acid
- 5-HIAA:
-
5-hydroxyindoleacetic acid
- ECS:
-
electroconvulsive shock
- ECT:
-
electroconvulsive therapy
References
Abrams R (1988) Electroconvulsive therapy. Oxford University Press, New York
Benveniste H (1989) Brain microdialysis. J Neurochem 52:1667–1679
Bergström DA, Kellar KJ (1979) Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature 278:464–466
Bhavsar VH, Dhuman VR, Kelkar VV (1981) The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats. Eur J Pharmacol 74:243–247
Butcher AP, Fairbrother IS, Kelly JS, Arbuthnott GW (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J Neurochem 50:346–355
Campbell BA, Fibiger HC (1971) Potentiation of amphetamine-induced arousal by starvation. Nature 233:424–425
Chiodo LA, Antelman SM (1980) Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 210:799–801
Cowen PJ, Nutt DJ, Green AR (1980) Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions — II: The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Neuropharmacology 19:901–906
Creese I, Kuczenski R, Segal D (1982) Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock. Pharmacol Biochem Behav 17:375–376
Damsma G, Day J, Fibiger HC (1989) Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 168:363–368
Damsma G, Boisvert DP, Mudrick LA, Wenkstern D, Fibiger HC (1990) Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis. J Neurochem 54:801–808
Deakin JFW, Owen F, Cross AJ, Dashwood MJ (1981) Studies on possible mechanisms of action of electroconvulsive therapy: effects of repeated electrically-induced seizures on rat brain receptors for monoamines and other neurotransmitters. Psychopharmacology 73:345–349
De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 180:31–35
Evans JPM, Grahame-Smith DG, Green AR, Tordoff AFC (1976) Electroconvulsive shock increases the behavioural response of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br J Pharmacol 56:193–199
Glue P, Costello MJ, Pert A, Mele A, Nutt DJ (1990) Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology 100:60–65
Grahame-Smith DG, Green AR, Costain DW (1978) Mechanism of the antidepressant action of electroconvulsive therapy. Lancet 1:254–256
Green AR (1978) Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses. Br J Pharmacol 62:325–331
Green AR, Heal DJ, Grahame-Smith DG (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52:195–200
Green AR, Costain DW, Deakin JFW (1980) Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions — III: The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses. Neuropharmacology 19:907–914
Green AR, Heal DJ, Johnson P, Laurence BE, Nimgaonkar VL (1983) Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine-and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex. Br J Pharmacol 80:377–385
Groves PM, Okuda G, Diane M (1990) Dopamine, depression and presynaptic receptors. In: Gessa GL, Serra G (eds) Dopamine and mental depression. Pergamon Press, New York, pp 109–120
Heal DJ, Green AR (1978) Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic AMP into the nucleus accumbens. Neuropharmacology 17:1085–1087
Heal DJ, Phillips AG, Green AR (1978) Studies on the locomotor activity produced by injection of dibutyryl cyclic 3′5′-AMP into the nucleus accumbens of rats. Neuropharmacology 17:265–270
Imperato A, Di Chiara G (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J Neurosci 4:966–977
Kalén P, Strecker RE, Rosengren E, Bjorklund A (1988): Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorometric detection. J Neurochem 51:1422–1435
Klimek V, Nielsen M (1987) Chronic treatment with antidepressants decreases the number of3H-SCH 23390 binding sites in rat striatum and the limbic system. Eur J Pharmacol 139:163–169
Kuczenski R, Segal DS, Manley LD (1990) Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates. J Neurochem 54:1492–1499
Lerer B, Jabotinsky-Rubin K, Bannet J, Ebstein RP, Belmaker RH (1982) Electroconvulsive shock prevents dopamine receptor supersensitivity. Eur J Pharmacol 80:131–134
Masserano JM, Takimoto GS, Weiner N (1981) Electroconvulsive shock increases tyrosine hydroxylase activity in the brain and adrenal gland of the rat. Science 214:662–664
Modigh K (1975) Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J Neural Transm 36:19–32
Modigh K (1976) Long-term effects of electroconvulsive shock therapy on synthesis turnover and uptake of brain monoamines. Psychopharmacology 49:179–185
Modigh K, Balldin J, Eriksson E, Granerus AK, Walinder J (1984) Increased responsiveness of dopamine receptor after ECT: a review of experimental and clinical evidence. In: Lerer B, Weiner RD, Belmaker RH (eds) ECT: basic mechanisms. John Libbey, London, pp 18–27
Newman ME, Lerer B (1989) Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat. Neuropharmacology 28:787–790
Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6:106–112
Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1991) Chronic desipramine treatment enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur J Pharmacol 195:63–73
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York
Pryor GT (1974) Effect of repeated ECS on brain weight and brain enzymes. In: Fink M, Kety S, McGaugh J, Williams TA (eds) Psychobiology of convulsive therapy. Winston & Sons, Washington, DC, pp 171–184
Radhakishun FS, Westerink BHC, van Ree JM (1988) Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and neuroleptic-like peptide desenkephalin-γ-endorphin, Neurosci Lett 89:328–334
Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S (1987a) Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry 22:249–268
Sackeim H, Decina P, Prohovnik I, Malitz S (1987b) Seizure threshold in electroconvulsive therapy. Arch Gen Psychiatry 44:355–360
Serra G, Argiolas A, Fadda F, Melis MR, Gessa GL (1981) Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine. Psychopharmacology 73:194–196
Sharp T, Kingston J, Grahame-Smith DG (1990) Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats. Psychopharmacology 100:110–114
Tepper JM, Nakamura S, Spanis CW, Squire LR, Young SJ, Groves PM (1982) Subsensitivity of catecholaminergic neurons to direct acting agonists after single or repeated electroconvulsive shock. Biol Psychiatry 17[10]:1059–1071
Ungerstedt U (1984) Measurement of neurotransmitter release by intracranial dialysis. In: Marsden CA (ed) Measurement of neurotransmitter release. Wiley, London, pp 81–105
Westerink BHC, Tuinte MHJ (1986) Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid. J Neurochem 46:181–185
Westerink BHC, de Vries JB (1988) Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J Neurochem 51:683–687
Wielosz M (1981) Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats. Neuropharmacology 20:941–945
Zetterström T, Ungerstedt U (1984) Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. Eur J Pharmacol 97:29–36
Zetterström T, Sharp T, Ungerstedt U (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur J Pharmacol 132:1–9
Zetterström T, Sharp T, Collin AK, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 148:327–334
Zis AP, Nomikos GG, Damsma G, Fibiger HC (1991) In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum. Psychopharmacology 103:343–350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nomikos, G.G., Zis, A.P., Damsma, G. et al. Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens. Psychopharmacology 105, 230–238 (1991). https://doi.org/10.1007/BF02244315
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244315